That is essential, since the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be effective. To put it simply, we have to understand how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental process (diplomatic relations). Today, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're created to do. This was an advancement almost nobody observed. But it's going to have extensive implications for treating disease. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be a lot of investment chances in this area, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (artificial intelligence). That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it pulled back perhaps substantially prior to going higher - jeff brown. I have actually been covering bitcoin for a very long time now. Among the very first research reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial suggestion, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mostly educating readers. But that's not the huge question anymore. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So consider that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. jeff brown genome sequencing stock. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These companies raised a total of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are so lots of terrific personal companies on the edge of hitting the general public markets And I've been working on a new way for you to invest even prior to these companies go public.
This chance has been constructing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the information. Go right here to reserve your area free of charge.
Emma Walsh here, managing editor of the Journal. Regular Diary readers know that tech isn't our usual beat (future report). And when it pertains to tech investing, we leave it to the specialists. Thankfully, we have numerous such professionals in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing specialists we know (the legacy report predictions). In reality, he had numerous triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge picture and forecast what's just around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and a lot more. These trends are experiencing rapid growth and creating amazing opportunities for financiers. I wish to make certain all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. exponential tech investor. However despite what lots of readers may think, this is a trend that's simply getting begun. Despite the fact that the COVID-19 pandemic interfered with supply chains in 2015, a remarkable 250 million 5G-enabled devices were still sold.
And all of this ultimately caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown stock market prediction). Losing two months of production and sales actually affects the number of 5G gadgets are offered in the fiscal year. When you consider all of that, offering 250 million systems is exceptional. More notably, the delays triggered by the pandemic created a load of bottled-up need. Which demand is now going to be pressed into 2021. In truth, I forecast that more than 500 million 5G devices will be shipped in 2021 - jeff brown biotech stock pick for 2020. Which's not my only 5G prediction When I have actually discussed 5G in the past, I have actually described its 3 different stages.
In Stage Two, 5G gadgets go on sale. 5G phones and other products begin to reach customers. And in Stage 3, 5G services start to be provided (longtime readers). That's when we start to see applications working on 5G networks. Think of things like enormous multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will begin Phase 3 by this summertime. This begins something of a virtuous cycle: Many people do not actually care about the innovation. But they will care if there are amazing applications that can just be accessed with a 5G phone.
That results in more 5G apps being established. In fact, 5G is going to open a suite of amazing applications: self-driving cars and trucks, the Web of Things, robotic surgery, and more. All of these technologies need 5G. The financial investment chances going forward will be massive. Stepping far from 5G, the next crucial innovation I anticipate in 2021 is CRISPR hereditary modifying. CRISPR stands for "clustered routinely interspaced short palindromic repeat." It's a mouthful. But it's one of the most interesting developments in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software.
The program can crash or not operate correctly. CRISPR uses a similar idea however with our hereditary code. "Typos" in our genome can result in disease. CRISPR can correct these "typos." For many years, CRISPR was mostly a specific niche innovation that wasn't well understood. And during that time, there were actually only 3 business operating in this space. However things are altering. CRISPR is no longer just theoretical. We're seeing actual results. We're treating illness and seeing that this technology just works. And as a result, a "second crop" of early-stage CRISPR business is going public and delivering unbelievable returns. This entire industry is successfully a greenfield opportunity.
There's room for lots of companies to exist in this space. jeff brown top biotech 2020. And there will be more. That's my prediction for CRISPR in 2021. I forecast that two or three more genetic modifying companies will hold their IPOs. Sticking with biotechnology, we are seeing amazing things occurring at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software application can precisely forecast the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That is necessary since the method a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and work.
Historically, this has been an experimental procedure. But now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're developed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however a number of drug therapies produced utilizing this technology. This was among those breakthroughs that almost no one discovered. But it's going to have profound implications for treating illness. And, of course, there will be lots of financial investment opportunities in this area, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be surprised if it drew back maybe considerably prior to going higher. I have actually been covering bitcoin for a long period of time now. Among the very first research study reports I ever published was on bitcoin - jeff brown 2021 predictions. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my suggestion. But at the time of that initial recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. last week. Mass, Mutual is a 150-year-old organization. So believe about that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the info depends on date as of February 2021, however we could not individually validate this claim. Provided Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down a precise figure at this minute. Brown is best known for his sage-like ability to select winning technology stocks. He invested more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an exceptional perspective on the market. He's constantly on the hunt for new opportunities, and he shares many of his best choices in the Future Report.
That's high appreciation, but it's not absurdly reasoned. Brown has an excellent credibility as a stock-picker, and he effectively forecasted some of the greatest financial events of the past twenty years. Although he does not appear to launch his choices to the general public, the service's success is a direct indicator of Brown's stock-picking prowess. Nobody on Wall Street gets it ideal each time, however Jeff Brown's precise predictions have made him legions of devoted fans. That states a lot about his ability. The Future Report is released by Brownstone Research study, a popular financial research publisher. Brownstone Research study provides numerous research services with a variety of specializations - tech stocks.
The company is likewise associated with Bonner & Partners, another well-respected research study publisher - bleeding edge. On its website, Brownstone says its objective is to offer retail investors with professional-grade research study: "For too long, the very best investment research study has actually not been readily available to individual investors. It has been typically scheduled for financial investment banks, hedge funds, private equity, and high-net-worth clients. first lady. The objective of Brownstone Research study is to make that kind of exclusive research study readily available to any investors looking to get an edge in the marketplaces. The goal is easy to deliver special and lucrative investment research study found nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise acts as the company's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to offer its customers. After years of constant success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a family name throughout most of America. If you know even a little bit about the market, you know that he has a reputation as a King Midas of sorts. jeff brown stock picks 2021. Everything he touches turns to gold! Jeff is well aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge job.
In fact, Brown thinks S.A.V. brownstone research. might be "the most significant trend of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying two innovative technologies: artificial intelligence and electrical automobiles. Musk hopes the mix will help him develop the first fully-autonomous, self-driving automobiles ever. It's absolutely nothing brief of the automotive market's Holy Grail. As you know, electrical vehicles and self-driving automobile stocks have been substantial this year, however the Wall Street machine has approved buzz without much tangible result. Despite a drastic boost in competition over the previous few years, Brown still believes Musk has the very best chance of putting everything together.
tech might be the magic string that connects all of it together. S.A.V. means Shared Autonomous Vehicle, and it might be the future of transportation. Generally, this innovation would allow you to rent your vehicle as a self-governing, self-driving taxi when you're not using it. You simply leave the cars and truck and press a button on an app that informs the cars and truck to "sign up with the fleet." Next thing you understand, you're unwinding on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a large piece of the profits. It sounds outrageous, however it might be closed than you think.